AR
Adcock Richard
董事长兼首席执行官
C-suiteM
内部人交易记录
首席执行官基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the complete record of transactions filed by Adcock Richard, 董事长兼首席执行官. Director active across 1 company, notably ImmunityBio, Inc.. Aggregated, 16 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €54. Activity tracked since 9 September 2021. The latest transaction was filed on 22 February 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Adcock Richard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
77,560 股@ US$8.7049.5% 占其流量Common StockSEC:0001830328-26-000005:1
152,439 股0Common StockSEC:0001830328-26-000005:0
274,122 股0Common StockSEC:0001830328-26-000003:0
34,483 股0Common StockSEC:0001830328-26-000001:0
78,167 股@ US$3.4222.0% 占其流量Common StockSEC:0001326110-25-000021:1
152,439 股0Common StockSEC:0001326110-25-000021:0
34,483 股0Common StockSEC:0001326110-25-000004:0
83,334 股0Common StockSEC:0001326110-24-000018:0
43,165 股@ US$4.0414.0% 占其流量Common StockSEC:0001326110-24-000018:1
34,483 股0Common StockSEC:0001326110-24-000007:0
42,192 股@ US$4.3314.5% 占其流量Common StockSEC:0001326110-23-000010:1
83,333 股0Common StockSEC:0001326110-23-000010:0
8,620 股0Common StockSEC:0001326110-23-000004:0
83,333 股0Common StockSEC:0001326110-22-000006:0
7 股@ US$9.000.0% 占其流量Common StockSEC:0001326110-21-000005:0
8,620 股0Common StockSEC:0001209191-21-055785:0
About Adcock Richard
Adcock Richard is Président-Directeur Général and at ImmunityBio, Inc. (XNAS) serves as CEO & President. He has 16 filings in total, and across the recent filings tracked, the period runs from 2021-09-13 to 2026-02-24, with buy volume of EUR 54 and no sell volume, and the most common transaction nature is option exercise.